244 related articles for article (PubMed ID: 27490685)
1. Biomarkers for Presymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients.
Todorova VK; Makhoul I; Siegel ER; Wei J; Stone A; Carter W; Beggs ML; Owen A; Klimberg VS
PLoS One; 2016; 11(8):e0160224. PubMed ID: 27490685
[TBL] [Abstract][Full Text] [Related]
2. Immune response proteins as predictive biomarkers of doxorubicin-induced cardiotoxicity in breast cancer patients.
Yu LR; Cao Z; Makhoul I; Daniels JR; Klimberg S; Wei JY; Bai JP; Li J; Lathrop JT; Beger RD; Todorova VK
Exp Biol Med (Maywood); 2018 Feb; 243(3):248-255. PubMed ID: 29224368
[TBL] [Abstract][Full Text] [Related]
3. Circulating miRNA Profiles of Doxorubicin-induced Cardiotoxicity in Breast Cancer Patients.
Todorova VK; Makhoul I; Wei J; Klimberg VS
Ann Clin Lab Sci; 2017 Mar; 47(2):115-119. PubMed ID: 28442511
[TBL] [Abstract][Full Text] [Related]
4. Transcriptome profiling of peripheral blood cells identifies potential biomarkers for doxorubicin cardiotoxicity in a rat model.
Todorova VK; Beggs ML; Delongchamp RR; Dhakal I; Makhoul I; Wei JY; Klimberg VS
PLoS One; 2012; 7(11):e48398. PubMed ID: 23209553
[TBL] [Abstract][Full Text] [Related]
5. Candidate early predictive plasma protein markers of doxorubicin-induced chronic cardiotoxicity in B6C3F
Desai VG; Lee T; Moland CL; Vijay V; Han T; Lewis SM; Herman EH; Fuscoe JC
Toxicol Appl Pharmacol; 2019 Jan; 363():164-173. PubMed ID: 30517846
[TBL] [Abstract][Full Text] [Related]
6. Early decline in left ventricular ejection fraction predicts doxorubicin cardiotoxicity in lymphoma patients.
Nousiainen T; Jantunen E; Vanninen E; Hartikainen J
Br J Cancer; 2002 Jun; 86(11):1697-700. PubMed ID: 12087452
[TBL] [Abstract][Full Text] [Related]
7. A Chemosensitizer Drug: Disulfiram Prevents Doxorubicin-Induced Cardiac Dysfunction and Oxidative Stress in Rats.
Sonawane VK; Mahajan UB; Shinde SD; Chatterjee S; Chaudhari SS; Bhangale HA; Ojha S; Goyal SN; Kundu CN; Patil CR
Cardiovasc Toxicol; 2018 Oct; 18(5):459-470. PubMed ID: 29779119
[TBL] [Abstract][Full Text] [Related]
8. Early metabolomics changes in heart and plasma during chronic doxorubicin treatment in B6C3F1 mice.
Schnackenberg LK; Pence L; Vijay V; Moland CL; George N; Cao Z; Yu LR; Fuscoe JC; Beger RD; Desai VG
J Appl Toxicol; 2016 Nov; 36(11):1486-95. PubMed ID: 26934058
[TBL] [Abstract][Full Text] [Related]
9. Liposomal doxorubicin attenuates cardiotoxicity via induction of interferon-related DNA damage resistance.
Gyöngyösi M; Lukovic D; Zlabinger K; Spannbauer A; Gugerell A; Pavo N; Traxler D; Pils D; Maurer G; Jakab A; Riesenhuber M; Pircher A; Winkler J; Bergler-Klein J
Cardiovasc Res; 2020 Apr; 116(5):970-982. PubMed ID: 31346605
[TBL] [Abstract][Full Text] [Related]
10. Cardiac autonomic modulation induced by doxorubicin in a rodent model of colorectal cancer and the influence of fullerenol pretreatment.
Potočnik N; Perše M; Cerar A; Injac R; Finderle Ž
PLoS One; 2017; 12(7):e0181632. PubMed ID: 28727839
[TBL] [Abstract][Full Text] [Related]
11. Circulating mir-208a fails as a biomarker of doxorubicin-induced cardiotoxicity in breast cancer patients.
Oliveira-Carvalho V; Ferreira LR; Bocchi EA
J Appl Toxicol; 2015 Sep; 35(9):1071-2. PubMed ID: 26046768
[No Abstract] [Full Text] [Related]
12. Upregulation of let-7f-2-3p by long noncoding RNA NEAT1 inhibits XPO1-mediated HAX-1 nuclear export in both in vitro and in vivo rodent models of doxorubicin-induced cardiotoxicity.
Liu Y; Duan C; Liu W; Chen X; Wang Y; Liu X; Yue J; Yang J; Zhou X
Arch Toxicol; 2019 Nov; 93(11):3261-3276. PubMed ID: 31570982
[TBL] [Abstract][Full Text] [Related]
13. Plasmatic and chamber-specific modulation of cardiac microRNAs in an acute model of DOX-induced cardiotoxicity.
Gioffré S; Ricci V; Vavassori C; Ruggeri C; Chiesa M; Alfieri I; Zorzan S; Buzzetti M; Milano G; Scopece A; Castiglioni L; Sironi L; Pompilio G; Colombo GI; D'Alessandra Y
Biomed Pharmacother; 2019 Feb; 110():1-8. PubMed ID: 30453253
[TBL] [Abstract][Full Text] [Related]
14. TLR2 and TLR3 expression as a biomarker for the risk of doxorubicin-induced heart failure.
Liang S; Xinyong C; Hongmin Z; Jing W; Lang H; Ping Z
Toxicol Lett; 2018 Oct; 295():205-211. PubMed ID: 29959987
[TBL] [Abstract][Full Text] [Related]
15. Sex-related differential susceptibility to doxorubicin-induced cardiotoxicity in B6C3F
Jenkins GR; Lee T; Moland CL; Vijay V; Herman EH; Lewis SM; Davis KJ; Muskhelishvili L; Kerr S; Fuscoe JC; Desai VG
Toxicol Appl Pharmacol; 2016 Nov; 310():159-174. PubMed ID: 27644598
[TBL] [Abstract][Full Text] [Related]
16. Cardiotoxicity of doxorubicin/paclitaxel combination in rats: effect of sequence and timing of administration.
Saad SY; Najjar TA; Alashari M
J Biochem Mol Toxicol; 2004; 18(2):78-86. PubMed ID: 15122649
[TBL] [Abstract][Full Text] [Related]
17. Incidence and risk factors associated with development of clinical cardiotoxicity in dogs receiving doxorubicin.
Hallman BE; Hauck ML; Williams LE; Hess PR; Suter SE
J Vet Intern Med; 2019 Mar; 33(2):783-791. PubMed ID: 30697816
[TBL] [Abstract][Full Text] [Related]
18. Near infra-red laser mediated photothermal and antitumor efficacy of doxorubicin conjugated gold nanorods with reduced cardiotoxicity in swiss albino mice.
Arunkumar P; Raju B; Vasantharaja R; Vijayaraghavan S; Preetham Kumar B; Jeganathan K; Premkumar K
Nanomedicine; 2015 Aug; 11(6):1435-44. PubMed ID: 25881739
[TBL] [Abstract][Full Text] [Related]
19. Edaravone and benidipine protect myocardial damage by regulating mitochondrial stress, apoptosis signalling and cardiac biomarkers against doxorubicin-induced cardiotoxicity.
Hassan MQ; Akhtar MS; Afzal O; Hussain I; Akhtar M; Haque SE; Najmi AK
Clin Exp Hypertens; 2020 Jul; 42(5):381-392. PubMed ID: 31630586
[No Abstract] [Full Text] [Related]
20. Epigallocatechin-3-gallate pretreatment attenuates doxorubicin-induced cardiotoxicity in rats: A mechanistic study.
Saeed NM; El-Naga RN; El-Bakly WM; Abdel-Rahman HM; Salah ElDin RA; El-Demerdash E
Biochem Pharmacol; 2015 Jun; 95(3):145-55. PubMed ID: 25701654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
